Beranda › Trombositemia Esensial › North Carolina › Durham
Uji klinis Trombositemia Esensial di Durham, NC
6 studi untuk Trombositemia Esensial mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Menerima pesertaFase 3
- Duke University Medical Center, Durham
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi jauhnya
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
- Duke University Medical Center, Department of Hematologic Malignancies and Cellular Therapy, Durham
- University of North Carolina At Chapel Hill, Chapel Hill · 10 mi jauhnya
Registry of Older Patients With Cancer
Menerima pesertaStudi observasional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauhnya
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
Menerima pesertaFase 3
- DUHS Duke Blood Cancer Center ( Site 6005), Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Menerima pesertaStudi observasional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauhnya
Uji klinis Trombositemia Esensial di kota lain
- New York City, NY7 studi
- Chicago, IL4 studi
- Salt Lake City, UT4 studi
- Nashville, TN4 studi
- Baltimore, MD4 studi
- Miami, FL4 studi
- Boston, MA4 studi
- Mountain View, CA4 studi
- Houston, TX3 studi
- Cleveland, OH3 studi
- Irvine, CA3 studi
- Columbus, OH3 studi
Studi lain di Durham
- Kanker Payudara63 studi
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil39 studi
- Mieloma Multipel37 studi
- Kanker Metastatik33 studi
- Leukemia Mieloid Akut33 studi
- Kanker Paru32 studi
- Kanker Prostat32 studi
- Kanker Kolorektal28 studi
- Leukemia Limfositik Kronis27 studi
- Kanker Ovarium27 studi
- Gagal Jantung26 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.